These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 8381351

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
    Hamaguchi M, Xiao H, Uehara Y, Ohnishi Y, Nagai Y.
    Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.
    Uehara Y, Fukazawa H.
    Methods Enzymol; 1991 Mar; 201():370-9. PubMed ID: 1658554
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regulated binding of PTP1B-like phosphatase to N-cadherin: control of cadherin-mediated adhesion by dephosphorylation of beta-catenin.
    Balsamo J, Leung T, Ernst H, Zanin MK, Hoffman S, Lilien J.
    J Cell Biol; 1996 Aug; 134(3):801-13. PubMed ID: 8707857
    [Abstract] [Full Text] [Related]

  • 8. v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells.
    Machida K, Matsuda S, Yamaki K, Senga T, Thant AA, Kurata H, Miyazaki K, Hayashi K, Okuda T, Kitamura T, Hayakawa T, Hamaguchi M.
    Oncogene; 2000 Mar 23; 19(13):1710-8. PubMed ID: 10763828
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro.
    Fukazawa H, Li PM, Yamamoto C, Murakami Y, Mizuno S, Uehara Y.
    Biochem Pharmacol; 1991 Oct 09; 42(9):1661-71. PubMed ID: 1656993
    [Abstract] [Full Text] [Related]

  • 13. A host-dependent temperature-sensitive mutant of Rous sarcoma virus: evidence for host factors affecting transformation.
    Young JC, Liebl E, Martin GS.
    Virology; 1988 Oct 09; 166(2):561-72. PubMed ID: 2845662
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of Rous sarcoma virus transformation mutants with differing tyrosine kinase activities to study the relationships between vinculin phosphorylation, pp60v-src location and adhesion plaque integrity.
    Kellie S, Patel B, Wigglesworth NM, Critchley DR, Wyke JA.
    Exp Cell Res; 1986 Jul 09; 165(1):216-28. PubMed ID: 3011478
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.
    Jong SM, Zong CS, Dorai T, Wang LH.
    J Virol; 1992 Aug 09; 66(8):4909-18. PubMed ID: 1321277
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.